Inside The Evolution Of Clinical Trials: Insights From Deepak Ananthan

As clinical trials grow more complex and data volumes continue to surge, the ability to turn information into insight has never been more critical. In a recent conversation ahead of the Clinical Trials Technology Congress, Deepak Ananthan shared a candid perspective on how clinical data strategy is evolving — and what that means for organisations navigating today’s research landscape.

The discussion explores why structured clinical data remains an underused asset and how improving data foundations can unlock faster analysis, better decision-making, and more adaptable trial operations. Deepak also weighs in on the expanding role of AI, highlighting where it can genuinely add value today versus where expectations may be running ahead of reality. Interoperability emerges as a central theme, with insights into why seamless data exchange is no longer optional for modern trials.

Patient-centric trial design rounds out the conversation, reframing it not as a compliance exercise but as a strategic advantage that can improve recruitment, retention, and data quality. Together, these perspectives offer a practical look at where clinical research is headed — and where leaders should focus their efforts now.